Department of Research, Division of Neonatology, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, USA.
Prostaglandins Other Lipid Mediat. 2009 Nov;90(1-2):21-5. doi: 10.1016/j.prostaglandins.2009.06.006. Epub 2009 Jun 25.
The aim of the present study was to compare the effects of genetic mPGES-1 loss and COX-2 inhibition on myocardial damage after coronary occlusion. mPGES-1(-/-) mice and their wild-type littermates were injected with vehicle or COX-2 inhibitor (celecoxib), and 30min later the left coronary artery was surgically occluded. At 24h, myocardial infarct (MI) volume was measured histologically. Post-MI survival was reduced in WT mice receiving celecoxib (12/20) compared with vehicle-treated controls (12/12) or the loss of mPGES-1 (13/13) together with increased phosphokinase (CPK) and cardiac troponin-I release. Endogenous mPGES-1 expression was unchanged by ischemia in WT mice and absent in mPGES-1(-/-) hearts. COX-2 expression was markedly increased at 24h after MI in WT hearts; this upregulation was largely attenuated in mPGES-1(-/-) mice. We conclude that loss of mPGES-1 prevents the upregulation of COX-2 after myocardial infarct, and in contrast to inhibition of COX-2, does not increase ischemic myocardial damage.
本研究旨在比较基因 mPGES-1 缺失和 COX-2 抑制对冠状动脉闭塞后心肌损伤的影响。mPGES-1(-/-) 小鼠及其野生型同窝仔鼠分别给予载体或 COX-2 抑制剂(塞来昔布),30min 后行左冠状动脉结扎术。24h 后,行心肌梗死(MI)体积组织学测量。与 vehicle 处理的对照组(12/12)或 mPGES-1 缺失(13/13)加用 COX-2 抑制剂的 WT 小鼠(12/20)相比,WT 小鼠给予塞来昔布后 MI 后存活时间缩短,同时心肌酶(CPK)和心肌肌钙蛋白-I 释放增加。WT 小鼠缺血后内源性 mPGES-1 表达无变化,mPGES-1(-/-) 心脏中则无表达。WT 心脏 MI 后 24h COX-2 表达明显增加;这种上调在 mPGES-1(-/-) 小鼠中则明显减弱。我们的结论是,mPGES-1 缺失可预防 MI 后 COX-2 的上调,与 COX-2 抑制不同,不会增加缺血性心肌损伤。